Combination Chemotherapy (FLAG-Ida) With Pivekimab Sunirine (PVEK [IMGN632]) for the Treatment of Newly Diagnosed Adverse Risk Acute Myeloid Leukemia and Other High-Grade Myeloid Neoplasms
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
St. Jude Children's Research Hospital
Stanford University
Medical College of Wisconsin
Dana-Farber Cancer Institute
City of Hope Medical Center
Fred Hutchinson Cancer Center
University of Alabama at Birmingham
Fred Hutchinson Cancer Center
Ossium Health, Inc.
Dartmouth-Hitchcock Medical Center
St. Jude Children's Research Hospital
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Children's Hospital Medical Center, Cincinnati
Fred Hutchinson Cancer Center
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
Center for International Blood and Marrow Transplant Research
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Northwestern University
University of Nebraska
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
Eastern Cooperative Oncology Group
University of Washington
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Virginia Commonwealth University
Memorial Sloan Kettering Cancer Center
University of Washington
H. Lee Moffitt Cancer Center and Research Institute
National Institutes of Health Clinical Center (CC)
Masonic Cancer Center, University of Minnesota
M.D. Anderson Cancer Center
Dartmouth-Hitchcock Medical Center
Washington University School of Medicine
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
St. Jude Children's Research Hospital
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Pittsburgh
M.D. Anderson Cancer Center
Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota
Shanghai Tong Ren Hospital